IL17RC and prostate neoplasm: Yang et al. (38) studied interleukin-17 receptor C (Il17rc), a subunit of the IL-17A receptor, in a mouse prostate tumor model and found significantly higher levels of PD-1 and PD-L1 in Il17rc wild-type tumors than in Il17rc knockdown tumors.